Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 158.00
+2.00 (1.28%)
Aug 26, 2026, 1:30 PM CST
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 15.88 billion as of August 25, 2026. Its market cap has increased by 18.07% in one year.
Market Cap
15.88B
Enterprise Value
15.05B
Revenue
1.08B
Ranking
n/a
PE Ratio
31.87
Stock Price
158.00
ChartMarket Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 15.88B, an increase of 211.53%. That is a compound annual growth rate of 15.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 15.88B | 10.51% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 23.97B |
| Oneness Biotech | 22.51B |
| Sunmax Biotechnology | 21.73B |
| Medigen Vaccine Biologics | 18.51B |
| TaiMed Biologics | 17.43B |
| EirGenix | 15.05B |
| Gongwin Biopharm Holdings | 14.00B |
| Lumosa Therapeutics | 12.98B |